Accessibility Menu

Revvity(FRA) PKN

Market Cap€12.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€109.80
+0.78%
+0.85Today

Revvity Financials at a Glance

Market Cap

€12.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.50K

Net Income (TTM)

€203.64

EPS (TTM)

€1.81

P/E Ratio

60.31

Dividend

€0.24

Beta (Volatility)

-0.01 (Low)

Price

€109.80

Volume

0

Open

€109.80

Previous Close

€108.95

Daily Range

€109.80 - €109.80

52-Week Range

€69.68 - €109.90

Estimated Earnings Date

N/A

PKN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Revvity

Revvity, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.

Industry

Life Sciences Tools and Services

Employees

11,000

CEO

Prahlad Ramadhar Singh, PhD, MBA

PKN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.19%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.66%

Dividend Yield

0.22%

Payout Ratio

N/A

Stock Overview

Market Cap

€12.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.59M

Volume

0

Avg. Volume

4.546

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Revvity Performance Analysis

Revvity annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 3,151,192,134-2.7%
20232023-12-31EUR 2,544,196,932-19.3%
20242024-12-31EUR 2,546,962,6910.1%
20252025-12-31EUR 2,530,663,477-0.6%
Revvity annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 4.28-37.4%
20232023-12-31EUR -0.88N/A
20242024-12-31EUR 2.23N/A
20252025-12-31EUR 1.84-17.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€627.58

+1.0%

Gross Profit

€315.44

+1.0%

Gross Margin

50.26%

+1.1%

Market Cap

€12.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.98

N/A

Employees

11,000

N/A

Net Income

€46.00

+0.9%

EBITDA

€196.04

+1.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€3.82K

+2.6%

Total Debt

€2.92K

+1.0%

Accounts Receivable

€620.29

+1.1%

Inventory

€331.06

+1.0%

Long Term Debt

€2.42K

+0.8%

Short Term Debt

€500.44

+2554.1%

Return on Assets

1.93%

+0.9%

Return on Invested Capital

3.62%

+0.6%

Free Cash Flow

€156.07

+1.7%

Operating Cash Flow

€165.69

+1.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About PKN

What is the current price of Revvity?

Revvity is trading at €109.80 per share.

What is the 52-week range for Revvity?

Over the past 52 weeks, Revvity has traded between €69.68 and €109.90.

How much debt does Revvity have?

As of the most recent reporting period, Revvity reported total debt of €2.92B.

How much cash does Revvity have on hand?

Revvity reported €895.35M in cash and cash equivalents in its most recent financial results.

What is Revvity’s dividend yield?

Revvity currently has a dividend yield of 0.22%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.